Bausch Health, after waylaying other copycats of its irritable bowel syndrome diarrhea (IBS-D) drug Xifaxan, has been dealt a blow in court. The court order potentially creates an opening for Norwich ...

The approval of Amneal Pharmaceuticals’ generic version of rifaximin 550 mg oral tablets is tentative due to the product’s involvement in litigation. The FDA's tentative approval of rifaximin 550 mg ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Rifaximin ...

Please provide your email address to receive an email when new articles are posted on . CHARLOTTE, N.C. — Daily treatment with Xifaxan over 2 weeks improved stool consistency and fecal urgency in ...

Rifaximin SSD failed to significantly delay the onset of HE in patients with liver cirrhosis, but Bausch is yet to scrap the ...

As an essential component of the drug development process, human clinical trials assist in determining whether a given drug will serve its intended purpose, but patent applicants should consider ...

Rifaximin, a topical antibiotic, appeared to be as effective as the low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet in managing irritable bowel syndrome ...

Nov. 2, 2005 (Honolulu) — Several gastrointestinal disorders beyond traveler's diarrhea respond to rifaximin (Xifaxan), according to investigators who presented their findings here at the 70th annual ...

Medicare Part D prescription drug coverage helps cover the cost of Xifaxan (rifaximin). Doctors may recommend Xifaxan to treat irritable bowel syndrome with diarrhea (IBS-D) or to help prevent overt ...

Most Medicare Part D prescription drug plans and Medicare Advantage plans with drug coverage include rifaximin (Xifaxan) for irritable bowel syndrome with diarrhea (IBS-D) and overt hepatic ...